Glycan-Imprinted Nanoparticle as Artificial Neutralizing Antibody for Efficient HIV-1 Recognition and Inhibition

Zhou et al. (Wed,) studied this question.

www.synapsesocial.com/papers/68e708c0b6db6435876822d3 — DOI: https://doi.org/10.1021/acs.nanolett.4c00142

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Selection and characterization of an HIV‐1 gp120‐binding affibody ligand· 2006 · 33 citations
2. HIV-1 Assembly, Budding, and Maturation· 2012 · 791 citations
3. Molecular imprinting: perspectives and applications· 2016 · 2,365 citations
4. Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin· 2004 · 482 citations
5. Topological N-glycosylation and site-specific N-glycan sulfation of influenza proteins in the highly expressed H1N1 candidate vaccines· 2017 · 39 citations